A quick and easy breath test could mean new hope in the early detection of pancreatic cancer, and medical experts say it could be the biggest breakthrough in the fight against the deadly disease in half a century.

The novel device is currently undergoing a large-scale clinical trial in the UK — known as the VAPOR study — and hopes are high.

The Imperial College London and the nonprofit Pancreatic Cancer UK have teamed up to launch the trial in 40 different locations across Scotland, Wales and England, with a target of 6,000 patients.

The test could bring early detection of pancreatic cancer. pancreaticcancer.org.uk

“The breath test has the potential to revolutionize the early detection of pancreatic cancer,” said Diana Jupp, CEO of Pancreatic Cancer UK, which is funding the

See Full Page